Zuellig Pharma acquires Zam-Buk & Vapex from Bayer, strengthening consumer healthcare portfolio across Asia Pacific.
Tag: Zuellig Pharma
Zuellig Pharma and Karo Healthcare strengthen partnership across key markets in Asia
Zuellig Pharma will be the exclusive commercialisation partner for Karo’s over-the-counter (OTC) brand Lamisil®, a product for the treatment of fungal infections, across Hong Kong, Malaysia, Philippines, Singapore, South Korea, Taiwan and Vietnam.